Sonora Investment Management Group LLC Purchases 85 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sonora Investment Management Group LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,025 shares of the medical equipment provider’s stock after purchasing an additional 85 shares during the period. Sonora Investment Management Group LLC’s holdings in Intuitive Surgical were worth $535,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the company. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the third quarter valued at about $38,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.3 %

Shares of ISRG opened at $580.18 on Friday. The firm has a fifty day simple moving average of $549.32 and a two-hundred day simple moving average of $507.50. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market capitalization of $206.65 billion, a P/E ratio of 90.51, a PEG ratio of 5.52 and a beta of 1.39.

Analysts Set New Price Targets

A number of research analysts have weighed in on ISRG shares. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday. They issued a “neutral” rating and a $550.00 target price on the stock. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Mizuho upped their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Barclays boosted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock valued at $15,357,560 over the last ninety days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.